News

Increased awareness of catatonia and its treatment among health care providers, especially in underresourced areas, is essential for improving patient outcomes.

Today marks 5 years since the World Health Organization declared COVID-19 a pandemic. These are the psychiatric impacts.

A single dose of psilocybin was associated with a significant and sustained reduction in depressive symptoms and possible improvement of PTSD and burnout experienced by clinicians from the front line of the COVID-19 pandemic.

Do we need to be saved from empathy, as Elon Musk suggests?

A new trial is testing a first-of-its-kind stem cell therapy for Parkinson disease, using a patient’s own reprogrammed cells to restore lost dopamine function.

In a survey capturing the lived experiences of individuals with schizophrenia on antipsychotic medications, 27% of participants reported that antipsychotics had done “more harm than good.”

To be successful, telehealth visits must come as close as possible to in-person appointments. One psychiatrist shares his best practices.

Here is a message to the women all over the world who need uplifting.

Does palliative psychiatry inevitably lead to advocacy for assisted suicide?

Here are highlights from this week in Psychiatric Times, including updates on the BHV-7000 for bipolar disorder trial and a new study on physician suicide rates.

Postpartum psychosis occurs in about 1 to 2 per thousand new mothers. In this personal story, one writer shares her experience with postpartum psychosis.

Epidemiological data show that rates of anxiety, depression, self-injurious behaviors, and suicidality increased for Gen Z in significantly higher numbers than previous generations.

More power and action are needed for women—now more than ever.

Learn more about the impact birth complications and life factors may have on postpartum depression.

The impacts of this pandemic continue to ripple. All we can do is try our best to stay informed. That’s where we come in.

We want to hear from you: what ethical issues in psychiatry are you most worried about?

The revolution has been televised. Check out these 8 psychiatric perspectives on the current state of politics.

A recent study found that ketamine and transcranial magnetic stimulation show promise in treating treatment-resistant depression in older adults.

A new study found that suicidal ideation and firearm access are the strongest predictors of veteran suicide risk.

Neurocrine Biosciences has initiated a phase 1 clinical study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of NBI-1140675 for certain neurological and neuropsychiatric conditions, such as tardive dyskinesia.

Dumb idea: We should expect rates of mental illness to melt away due to widespread treatment.

BLP-003, currently being evaluated for treatment-resistant depression and alcohol use disorder, today announced their global phase 2b clinical trial has completed patient enrollment.

A recent study found that female physicians have a 53% higher risk of suicide compared with the female general population.

How do psychiatrists and mental health professionals respond when faced with disaster? One psychiatrist shares his story.

Pipeline drug BHV-7000 failed to meet primary endpoint in a pivotal phase 2/3 trial for bipolar disorder; meanwhile, BHV-1300 sees success in sustained Reductions in Total IgG.

Vincenzo Di Nicola has won the Award for Leadership in Child, Adolescent, and Young Adult Psychiatry. Learn more about his thoughts on trauma, leadership, and issues in child and adolescent psychiatry.

Let’s examine some current events related to sadness and joy.

Celebrate Psychiatric Times’ 40th anniversary with a look back at some of our previous covers.

Do you want to be featured in a future Special Report? Check out our March theme!

Check out 2 bite-sized reviews of books related to mental health.